Price $79.44 |
Market Cap
10.62B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.9
|
P/B
3.22
|
P/S
1.02
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
20.5
|
Op. Cash Flow
571.8K
|
FCF
3.7
|
|
Op. Margin
5.60%
|
Net Margin
4.10%
|
ROE
13.70%
|
ROI
10.90%
|
|
ROA
5.70%
|
EPS Growth
-37.10%
|
Current Ratio
1.7
|
Debt/Equity
15.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $31.45 | - | - | 2.41B | Strong Buy |
| IntriCon Corporation (IIN) | $23.80 | - | - | 200M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.95 | - | - | 1.59B | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Apyx Medical Corp (APYX) | $9.26 | - | - | 365.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
